Kit ELISA Kallikrein 10 sandwich (Hu KLK10) (human): quantitative determination of Hu KLK10 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK10.
Accession number
O43240
Dose range
2.46-600 ng/ml
Sensitivity of the dosage
2 ng
Calibration range
2 ng/ml to 600 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Kallikrein 10 sandwich (Hu KLK10) (human): quantitative determination of Hu KLK10 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK10.
Kit ELISA Kallikrein 10 sandwich (Hu KLK10) (human): quantitative determination of Hu KLK10 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK10.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Kallikreins (KLK) belong to the serine protease family among proteolytic enzymes. The human pancreatic/renal KLK code for KLK1 enzyme, which is involved in the post-translational treatment of polypeptide precursors. The function of other members of the KLK gene family is currently unknown, but there is evidence that many KLKs are involved in carcinogeny. The human KLK gene family consists of 15 serine proteases. Human KLK genes are grouped on chromosome 19 q13. Unlike other kallikreins, KLK4 to 15 coded proteases are less bound and do not contain conventional KLK loops. Gene groups have a highly prostatic expression (KLK2 to 4, KLK15) or pancreatic expression (KLK6 to 13). KLK2 is also known as glandular kallidein 2, tissue kalikrin or HGK-1 and KLK3 is known as specific prostate antigen (PSA). KLK2 and KLK3 have important applications in the diagnosis of prostate and breast cancer. KLK4, KLK5, KLK9, KLK13, KLK12 and KLK14 were previously known as KLK-L1, KLK-L2, KLK-L3, KLK-L4, KLK-L5 and KLK-L6, respectively. Many KLKs are regulated by steroid hormones and some of them, particularly KLK3, KLK6 and KLK10, are known to be deregulated in breast cancer and other cancers.